Table 2.
Characteristics of referral for radiation therapy (n = 44 by patient)
| Characteristic | Value |
|---|---|
| Initial RT referral | |
| Age at referral (yr) | 57 (29–75) |
| Response to adjuvant chemotherapy | |
| Sensitive | 27 (61.4) |
| Resistant | 17 (38.6) |
| Number of sites involved with tumor | |
| Single | 12 (27.3) |
| Multiple | 32 (72.7) |
| RT site | |
| LN | 19 |
| Brain | 14 |
| Bone | 7 |
| Pelvic cavity | 4 |
| CA-125a) (U/mL) | |
| Before palliation RT | 46.2 (2.2–1,650.0) |
| After palliation RT | 23.2 (1.7–3,940.0) |
| Multiple RT Referral | |
| Number of referrals | |
| 1 | 29 (65.9) |
| 2 | 12 (27.3) |
| 3 | 3 (6.8) |
| Site of subsequent RT | |
| Newly recurred out-of-field site | 10 (10.6) |
| Re-irradiation of previous site | 4 (9.1) |
| Both | 1 (2.3) |
Values are presented as median (range) or number of patients (%).
RT, radiotherapy; LN, lymph node.
a)
Normal range defined as CA-125 <35 U/mL.